Angiotensin inhibitor vaccine (BTG)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAngiotensin inhibitor vaccine (BTG)
Drug Alias NamePMD 3117Angiotension Therapeutic VaccineHypertension vaccine - BTGPMD-3117
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsAngiotensin I antagonists
TargetsAngiotensin I
Therapy Area/IndicationsObesityMetabolic SyndromeInsulin Resistance +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProtherics
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University
Inactive CompaniesN/A
Active IndicationsObesityMetabolic SyndromeInsulin Resistance +[4] 
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeN/A
Related LinksN/A